Related Experiment Video
Updated: Feb 14, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept
Geneviève M Gavigan1,2, Nordau D Kanigsberg1,2, Michele L Ramien1,2
11 Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
Abstract:
We report a case of an 11-year-old female with Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) overlap, most likely triggered by sulfamethoxazole-trimethoprim, who was treated with the combination of methylprednisolone, cyclosporine, and etanercept. Her condition stabilized and her skin involvement did not progress after the addition of etanercept. To our knowledge, this is the first report of etanercept for pediatric SJS/TEN.
Related Concept Videos
Toxicity Testing in Animals
Pharmacokinetics in Pediatric Patients: Drug Excretion
Renewal of Skin Epidermal Stem Cells
Clinical Applications of Epidermal Stem Cells
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Overview

